First wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate

dc.contributor.affiliationUniversidad del Desarrollo
dc.contributor.affiliationUniversidad de Talca
dc.contributor.affiliationUniversidad de Las Americas - Chile
dc.contributor.authorVial, Pablo A.
dc.contributor.authorGonzalez, Claudia
dc.contributor.authorApablaza, Mauricio
dc.contributor.authorVial, Cecilia
dc.contributor.authorLavin, M.Estela
dc.contributor.authorAraos, Rafael
dc.contributor.authorRubilar, Paola
dc.contributor.authorIcaza, Gloria
dc.contributor.authorFlorea, Andrei
dc.contributor.authorPerez, Claudia
dc.contributor.authorConcha, Paula
dc.contributor.authorBastias, Diego
dc.contributor.authorErrazuriz, Maria Paz
dc.contributor.authorPerez, Ruth
dc.contributor.authorGuzman, Francisco
dc.contributor.authorOlea, Andrea
dc.contributor.authorGuzman, Eugenio
dc.contributor.authorCorrea, Juan
dc.contributor.authorMunita, Jose Manuel
dc.contributor.authorAguilera, Ximena
dc.date.accessioned2022-08-11T22:53:36Z
dc.date.available2022-08-11T22:53:36Z
dc.date.issued2022-09
dc.description.abstractBackground: The first wave of SARS-CoV-2 infection in Chile occurred during the cold season reaching a peak by the end of June 2020, with 80 % of the cases concentrated in its capital, Santiago. The main objective of this study was to estimate the attack rate during this first wave of SARS-CoV-2 in a large, densely populated city with more than seven million inhabitants. Since the number of confirmed cases provides biased information due to individuals' potential self-selection, mostly related to asymptomatic patients and testing access, we measured antibodies against SARS-CoV-2 to assess infection prevalence during the first wave in the city, as well as estimate asymptomatic cases, and infection fatality ratio. To our knowledge this is one of the few population-based crosssectional serosurvey during the first wave in a highly affected emerging country. The challenges of pandemic response in urban settings in a capital city like Santiago, with heterogeneous subpopulations and high mobility through public transportation, highlight the necessity of more accurate information regarding the first waves of new emerging diseases.Methods: From April 24 to June 21, 2020, 1326 individuals were sampled from a long-standing panel of household representatives of Santiago. Immunochromatographic assays were used to detect IgM and IgG antibody isotypes.Results: Seroprevalence reached 6.79 % (95 %CI 5.58 %-8.26 %) in the first 107 days of the pandemic, without significant differences among sex and age groups; this figure indicates an attack rate 2.8 times higher than the one calculated with registered cases. It also changes the fatality rate estimates, from a 2.33 % case fatality rate reported by MOH to an estimated crude 1.00 % (CI95 % 0.97-1.03) infection fatality rate (adjusted for test performance 1.66 % [CI95 % 1.61-1.71]). Most seropositive were symptomatic (81,1 %).Conclusions: Despite the high number of cases registered, mortality rates, and the stress produced over the health system, the vast majority of the people remained susceptible to potential new epidemic waves. We contribute to the understanding of the initial spread of emerging epidemic threats. Consequently, our results provide better information to design early strategies that counterattack new health challenges in urban contexts.
dc.description.sponsorshipUniversidad del Desarrollo Santiago, Chile [202001]; To the panel participants and their families. This work was supported by a COVID-19 Emergency Funding Effort #202001 by Universidad del Desarrollo Santiago, Chile.
dc.format.mimetypeapplication/pdf
dc.identifier.citationEpidemics, 40, 100606. https://doi.org/10.1016/j.epidem.2022.100606
dc.identifier.doihttps://doi.org/10.1016/j.epidem.2022.100606
dc.identifier.issn1755-4365
dc.identifier.orcidhttps://orcid.org/0000-0002-4135-0416
dc.identifier.orcidhttps://orcid.org/0000-0002-3192-3428
dc.identifier.orcidhttps://orcid.org/0000-0002-8153-6733
dc.identifier.orcidhttps://orcid.org/0000-0001-8075-0626
dc.identifier.orcidhttps://orcid.org/0000-0003-1306-3791
dc.identifier.orcidhttps://orcid.org/0000-0002-0612-8780
dc.identifier.orcidhttps://orcid.org/0000-0003-2385-3455
dc.identifier.orcidhttps://orcid.org/0000-0002-7870-1056
dc.identifier.orcidhttps://orcid.org/0000-0002-0399-6144
dc.identifier.orcidhttps://orcid.org/0000-0003-3578-459X
dc.identifier.pmid35872438
dc.identifier.researcheridJOJ-6799-2023
dc.identifier.researcheridD-9861-2014
dc.identifier.researcheridHZJ-5414-2023
dc.identifier.researcheridG-7589-2016
dc.identifier.researcheridISA-7550-2023
dc.identifier.researcheridKJL-9752-2024
dc.identifier.researcheridGVS-4266-2022
dc.identifier.rorhttps://ror.org/05y33vv83
dc.identifier.rorhttps://ror.org/028ynny55
dc.identifier.rorhttps://ror.org/01s4gpq44
dc.identifier.rorhttps://ror.org/0166e9x11
dc.identifier.scopusauthorid17339613100
dc.identifier.scopusauthorid16241501200
dc.identifier.scopusauthorid56845856600
dc.identifier.scopusauthorid55553152400
dc.identifier.scopusauthorid57435798400
dc.identifier.scopusauthorid34976138500
dc.identifier.scopusauthorid57031794200
dc.identifier.scopusauthorid6603110170
dc.identifier.scopusauthorid57435864000
dc.identifier.scopusauthorid56779441600
dc.identifier.scopusauthorid57435749700
dc.identifier.scopusauthorid57898476900
dc.identifier.scopusauthorid57814383300
dc.identifier.scopusauthorid56992094400
dc.identifier.scopusauthorid57814383400
dc.identifier.scopusauthorid36838940600
dc.identifier.scopusauthorid59361840900
dc.identifier.scopusauthorid58817630500
dc.identifier.scopusauthorid24825037700
dc.identifier.scopusauthorid6603011009
dc.identifier.urihttps://repositorio.udla.cl/handle/udla/1125
dc.language.isoeng
dc.publisherElsevier BV
dc.relation.fundingUniversidad del Desarrollo Santiago
dc.relation.fundingUniversidad del Desarrollo Santiago, Chile [202001]
dc.relation.isindexedbyWeb of Science
dc.relation.issn1755-4365
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://www.elsevier.com/tdm/userlicense/1.0/
dc.sourceEPIDEMICS
dc.source.urihttps://doi.org/10.1016/j.epidem.2022.100606
dc.subjectChile
dc.subjectSeroprevalence
dc.subjectCOVID-19
dc.subjectPandemic
dc.subjectSARS-COV-2
dc.subjectInfection fatality rate
dc.subjectIgG
dc.subjectIgM
dc.subjectFirst wave
dc.subject.lcshCOVID-19 (Disease)
dc.subject.lcshPandemics
dc.subject.oecd13 Ciencias Médicas y de la Salud
dc.subject.oecd23.3 Ciencias de la Salud
dc.subject.oecd33.3.8 Enfermedades Infecciosas
dc.titleFirst wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate
dc.title.alternativeFirst wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate.
dc.typejournal article
dc.type.coarhttp://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.udla.catalogadorCBM
oaire.citation.titleEPIDEMICS
oaire.citation.volume40
udla.curacion.controljmvg
udla.odsODS 3: Salud y bienestar
udla.oecd.area3 Ciencias Médicas y de la Salud
udla.oecd.discipline3.3.8 Enfermedades Infecciosas
udla.oecd.subarea3.3 Ciencias de la Salud

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Vial.2022.First wave of SARS-CoV-2 in Santiago Chile Seroprevalence, asymptomatic infection and infection fatality rate.pdf
Size:
2.12 MB
Format:
Adobe Portable Document Format
Description:
Vial.2022.First wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections